Awardee OrganizationUNIVERSITY OF CALIFORNIA BERKELEY
Description
Abstract Text
The ability to manipulate the mouse genome through transgenic and knock-out or knock-in technologies
has revolutionized modern Immunology. The purpose of this core facility (Core B) is to integrate the
transgenic and gene targeting approach into the studies of host-pathogen interaction, a major thrust of the
program project "Mouse models for understanding host-pathogen interactions". This
Transgenic/Knockout Mouse Core will provide the critical technical capability to generate and to maintain
transgenic and mutant mice commonly used by two or more investigators of the program project (PPG).
In particular, this Core will complement Core C to provide transgenic mice expressing fluorescent proteins
to be used for imaging studies. Core B will also generate and distribute transgenic strains of mice as
needed by the individual investigator in the PPG. In aim 1, C57Bl/6 transgenic mice expressing
fluorescent genes, whose expression is driven by different promoter/enhancers will be generated and
maintained for use in video imaging experiments. These include mice expressing membrane Cyan
Fluorescent Protein (CFP) in dendritic cells or macrophages and mice with CFP or YFP (Yellow
Fluorescent Protein) expressed in all cell types. In aim 2, knock-out/knock-in mice with genes involved
in innate immunity will be maintained as well as back-crossed to C57BI/6 or Balb/c if necessary. These
mice, including DC- and macrophage-specific FADD-/-, MyD88-/-, IFN-alpha/betaR-/-, TRAIL-R-/-, NK deficient
mice, NKG2D-/-, IL-12/GFP (Green Fluorescent Protein) knock-in and lFN-gamma/GFP knock-in mice, will be
provided to investigators in the PPG for their biochemical, infection or imaging experiments. In aim 3,
Core B will generate and provide transgenic mice for the specific needs of the individual PPG
investigator. Completion of these aims is necessary and essential for the success of the PPG designed to
understand how the immune system interacts with model pathogens.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
124726725
UEI
GS3YEVSS12N6
Project Start Date
15-July-2006
Project End Date
30-June-2011
Budget Start Date
15-July-2006
Budget End Date
30-June-2007
Project Funding Information for 2006
Total Funding
$236,764
Direct Costs
$153,044
Indirect Costs
$83,720
Year
Funding IC
FY Total Cost by IC
2006
National Institute of Allergy and Infectious Diseases
$236,764
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1P01AI065831-01A1 9001
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1P01AI065831-01A1 9001
Patents
No Patents information available for 1P01AI065831-01A1 9001
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1P01AI065831-01A1 9001
Clinical Studies
No Clinical Studies information available for 1P01AI065831-01A1 9001
News and More
Related News Releases
No news release information available for 1P01AI065831-01A1 9001
History
No Historical information available for 1P01AI065831-01A1 9001
Similar Projects
No Similar Projects information available for 1P01AI065831-01A1 9001